
OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Dimethyl fumarate attenuates reactive microglia and long-term memory deficits following systemic immune challenge
Hallel C. Paraiso, Ping‐Chang Kuo, Eric T. Curfman, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 53
Hallel C. Paraiso, Ping‐Chang Kuo, Eric T. Curfman, et al.
Journal of Neuroinflammation (2018) Vol. 15, Iss. 1
Open Access | Times Cited: 53
Showing 1-25 of 53 citing articles:
Glycolysis – a key player in the inflammatory response
Gonzalo Soto‐Heredero, Manuel M. Gómez de las Heras, Enrique Gabandé‐Rodríguez, et al.
FEBS Journal (2020) Vol. 287, Iss. 16, pp. 3350-3369
Open Access | Times Cited: 395
Gonzalo Soto‐Heredero, Manuel M. Gómez de las Heras, Enrique Gabandé‐Rodríguez, et al.
FEBS Journal (2020) Vol. 287, Iss. 16, pp. 3350-3369
Open Access | Times Cited: 395
Immune Activation in Alzheimer Disease
Arnaud Mary, Renzo Mancuso, Michael T. Heneka
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 585-613
Closed Access | Times Cited: 19
Arnaud Mary, Renzo Mancuso, Michael T. Heneka
Annual Review of Immunology (2024) Vol. 42, Iss. 1, pp. 585-613
Closed Access | Times Cited: 19
Immunological Aspects of Approved MS Therapeutics
Paulus Rommer, Ron Milo, May Han, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 137
Paulus Rommer, Ron Milo, May Han, et al.
Frontiers in Immunology (2019) Vol. 10
Open Access | Times Cited: 137
Transcription factor NRF2 as a promising therapeutic target for Alzheimer’s disease
Zhuo Qu, Jiachen Sun, Wannian Zhang, et al.
Free Radical Biology and Medicine (2020) Vol. 159, pp. 87-102
Closed Access | Times Cited: 104
Zhuo Qu, Jiachen Sun, Wannian Zhang, et al.
Free Radical Biology and Medicine (2020) Vol. 159, pp. 87-102
Closed Access | Times Cited: 104
Contribution of the Nrf2 Pathway on Oxidative Damage and Mitochondrial Failure in Parkinson and Alzheimer’s Disease
Francisca Villavicencio Tejo, Rodrigo A. Quintanilla
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1069-1069
Open Access | Times Cited: 98
Francisca Villavicencio Tejo, Rodrigo A. Quintanilla
Antioxidants (2021) Vol. 10, Iss. 7, pp. 1069-1069
Open Access | Times Cited: 98
Antioxidant and Anti-inflammatory Effect of Nrf2 Inducer Dimethyl Fumarate in Neurodegenerative Diseases
Sarah Adriana Scuderi, Alessio Ardizzone, Irene Paterniti, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 630-630
Open Access | Times Cited: 88
Sarah Adriana Scuderi, Alessio Ardizzone, Irene Paterniti, et al.
Antioxidants (2020) Vol. 9, Iss. 7, pp. 630-630
Open Access | Times Cited: 88
Dimethyl itaconate, an itaconate derivative, exhibits immunomodulatory effects on neuroinflammation in experimental autoimmune encephalomyelitis
Ping‐Chang Kuo, Wen‐Tsan Weng, Barbara A. Scofield, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 80
Ping‐Chang Kuo, Wen‐Tsan Weng, Barbara A. Scofield, et al.
Journal of Neuroinflammation (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 80
When It Comes to an End: Oxidative Stress Crosstalk with Protein Aggregation and Neuroinflammation Induce Neurodegeneration
Patrycja Michalska, Rafael León
Antioxidants (2020) Vol. 9, Iss. 8, pp. 740-740
Open Access | Times Cited: 80
Patrycja Michalska, Rafael León
Antioxidants (2020) Vol. 9, Iss. 8, pp. 740-740
Open Access | Times Cited: 80
Dimethyl Fumarate and Its Esters: A Drug with Broad Clinical Utility?
Stephanie Kourakis, Cara A. Timpani, Judy B. de Haan, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 306-306
Open Access | Times Cited: 73
Stephanie Kourakis, Cara A. Timpani, Judy B. de Haan, et al.
Pharmaceuticals (2020) Vol. 13, Iss. 10, pp. 306-306
Open Access | Times Cited: 73
Role of Nrf2 in Synaptic Plasticity and Memory in Alzheimer’s Disease
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Cells (2021) Vol. 10, Iss. 8, pp. 1884-1884
Open Access | Times Cited: 69
Don A. Davies, Aida Adlimoghaddam, Benedict C. Albensi
Cells (2021) Vol. 10, Iss. 8, pp. 1884-1884
Open Access | Times Cited: 69
Dimethyl Fumarate Alleviates NLRP3 Inflammasome Activation in Microglia and Sickness Behavior in LPS-Challenged Mice
Bora Tastan, Burak I. Ariöz, Kemal Uğur Tüfekçi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
Bora Tastan, Burak I. Ariöz, Kemal Uğur Tüfekçi, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 69
Crosstalk between the mTOR and Nrf2/ARE signaling pathways as a target in the improvement of long-term potentiation
Artem P. Gureev, В. Н. Попов, Anatoly A. Starkov
Experimental Neurology (2020) Vol. 328, pp. 113285-113285
Open Access | Times Cited: 65
Artem P. Gureev, В. Н. Попов, Anatoly A. Starkov
Experimental Neurology (2020) Vol. 328, pp. 113285-113285
Open Access | Times Cited: 65
Nrf2/ARE Activators Improve Memory in Aged Mice via Maintaining of Mitochondrial Quality Control of Brain and the Modulation of Gut Microbiome
Irina S. Sadovnikova, Artem P. Gureev, Daria A. Ignatyeva, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 607-607
Open Access | Times Cited: 51
Irina S. Sadovnikova, Artem P. Gureev, Daria A. Ignatyeva, et al.
Pharmaceuticals (2021) Vol. 14, Iss. 7, pp. 607-607
Open Access | Times Cited: 51
Natural antioxidants that act against Alzheimer’s disease through modulation of the NRF2 pathway: a focus on their molecular mechanisms of action
Grammatiki Alexandra Sidiropoulou, Athanasios Metaxas, Malamati Kourti
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18
Grammatiki Alexandra Sidiropoulou, Athanasios Metaxas, Malamati Kourti
Frontiers in Endocrinology (2023) Vol. 14
Open Access | Times Cited: 18
Nrf2 activation rescues stress-induced depression-like behaviour and inflammatory responses in male but not female rats
Ryan T. McCallum, Rachel-Karson Thériault, Joshua D. Manduca, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
Ryan T. McCallum, Rachel-Karson Thériault, Joshua D. Manduca, et al.
Biology of Sex Differences (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 8
HYCO-3, a dual CO-releaser/Nrf2 activator, reduces tissue inflammation in mice challenged with lipopolysaccharide
Roberto Motterlini, Aniket Nikam, Sylvie Manin, et al.
Redox Biology (2018) Vol. 20, pp. 334-348
Open Access | Times Cited: 56
Roberto Motterlini, Aniket Nikam, Sylvie Manin, et al.
Redox Biology (2018) Vol. 20, pp. 334-348
Open Access | Times Cited: 56
Multiple sclerosis is linked to MAPKERK overactivity in microglia
George J.A. ten Bosch, Jolande Bolk, Bert A. ‘t Hart, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 8, pp. 1033-1042
Open Access | Times Cited: 41
George J.A. ten Bosch, Jolande Bolk, Bert A. ‘t Hart, et al.
Journal of Molecular Medicine (2021) Vol. 99, Iss. 8, pp. 1033-1042
Open Access | Times Cited: 41
Targeting Nrf2/HO-1 anti-oxidant signaling pathway in the progression of multiple sclerosis and influences on neurological dysfunctions
Shubham Upadhayay, Sidharth Mehan
Brain Disorders (2021) Vol. 3, pp. 100019-100019
Open Access | Times Cited: 41
Shubham Upadhayay, Sidharth Mehan
Brain Disorders (2021) Vol. 3, pp. 100019-100019
Open Access | Times Cited: 41
Dimethyl fumarate abridged tauo-/amyloidopathy in a D-Galactose/ovariectomy-induced Alzheimer's-like disease: Modulation of AMPK/SIRT-1, AKT/CREB/BDNF, AKT/GSK-3β, adiponectin/Adipo1R, and NF-κB/IL-1β/ROS trajectories
Israa M Abd El-Fatah, Heba M. A. Abdelrazek, Sherehan M. Ibrahim, et al.
Neurochemistry International (2021) Vol. 148, pp. 105082-105082
Closed Access | Times Cited: 37
Israa M Abd El-Fatah, Heba M. A. Abdelrazek, Sherehan M. Ibrahim, et al.
Neurochemistry International (2021) Vol. 148, pp. 105082-105082
Closed Access | Times Cited: 37
Role of NLRP3 Inflammasomes in Neuroinflammation Diseases
Sen Lin, Xifan Mei
European Neurology (2020) Vol. 83, Iss. 6, pp. 576-580
Open Access | Times Cited: 37
Sen Lin, Xifan Mei
European Neurology (2020) Vol. 83, Iss. 6, pp. 576-580
Open Access | Times Cited: 37
Potential Protective and Therapeutic Roles of the Nrf2 Pathway in Ocular Diseases: An Update
Ming-xuan Wang, Jing Zhao, Hong Zhang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-22
Open Access | Times Cited: 30
Ming-xuan Wang, Jing Zhao, Hong Zhang, et al.
Oxidative Medicine and Cellular Longevity (2020) Vol. 2020, pp. 1-22
Open Access | Times Cited: 30
Molecular Effects of FDA-Approved Multiple Sclerosis Drugs on Glial Cells and Neurons of the Central Nervous System
Kim M. A. De Kleijn, Gerard J.M. Martens
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4229-4229
Open Access | Times Cited: 30
Kim M. A. De Kleijn, Gerard J.M. Martens
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 12, pp. 4229-4229
Open Access | Times Cited: 30
Anti-Inflammatory Effects of Dimethyl Fumarate in Microglia via an Autophagy Dependent Pathway
Young‐Sun Lee, Deepak Prasad Gupta, Sung Hee Park, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27
Young‐Sun Lee, Deepak Prasad Gupta, Sung Hee Park, et al.
Frontiers in Pharmacology (2021) Vol. 12
Open Access | Times Cited: 27
Emerging Therapeutic Applications for Fumarates
Ayla Hoogendoorn, Thomas D. Avery, Jiahe Li, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 239-254
Open Access | Times Cited: 26
Ayla Hoogendoorn, Thomas D. Avery, Jiahe Li, et al.
Trends in Pharmacological Sciences (2021) Vol. 42, Iss. 4, pp. 239-254
Open Access | Times Cited: 26
Dimethyl Fumarate, an Approved Multiple Sclerosis Treatment, Reduces Brain Oxidative Stress in SIV-Infected Rhesus Macaques: Potential Therapeutic Repurposing for HIV Neuroprotection
Yoelvis García‐Mesa, He N. Xu, Patricia J. Vance, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 416-416
Open Access | Times Cited: 24
Yoelvis García‐Mesa, He N. Xu, Patricia J. Vance, et al.
Antioxidants (2021) Vol. 10, Iss. 3, pp. 416-416
Open Access | Times Cited: 24